Related Experiment Video
Updated: Feb 18, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Thyroid hormones derivatives reduce proliferation and induce cell death and DNA damage in ovarian cancer
Elena Shinderman-Maman1,2,3, Keren Cohen1,2,3, Dotan Moskovich1,2,3
1Translational Hemato-Oncology Laboratory, The Hematology Institute and Blood Bank, Meir Medical Center, Kfar-Saba, Israel.
Abstract:
Ovarian cancer is a highly aggressive disease and novel treatments are required. Thyroid hormones binding to αvβ3 integrin produced growth-promoting activities in ovarian cancer and we hypothesized that natural thyroid hormone derivatives may antagonize these actions. The effect of three antagonists, tetraiodoacetic acid (tetrac), triiodothyroacetic acid (triac) and 3-iodothyronamine (T1AM), on cell proliferation, cell death and DNA damage was studied in two ovarian cancer cell lines (OVCAR3 and A2780), normal hamster ovary control cells (CHOK1) and αvβ3-deficient or transfected HEK293 cells. A differential inhibition of cell proliferation was observed in ovarian cancer cells compared to CHOK1. In OVCAR3, an induction of cell cycle regulators was further shown. Apoptosis was confirmed (annexin-PI, SubG1/cell-cycle, apoptotic genes, caspase-3 and poly ADP ribose polymerase-1 (PARP-1) cleavage) and was reversed by a pan-caspase inhibitor. Induction in apoptosis inducing factor (AIF) was observed, suggesting a parallel caspase-independent mechanism. Integrin-involvement in triac/T1AM apoptotic action was shown in αvβ3-transfected HEK293 cells. Lastly, in ovarian cancer models, key proteins that coordinate recognition of DNA damage, ataxia-telangiectasia mutated (ATM) and PARP-1, were induced. To conclude, the cytotoxic potential of thyroid hormone derivatives, tetrac, triac and T1AM, in ovarian cancer may provide a much-needed novel therapeutic approach.
Insights
Natural thyroid hormone derivatives like tetrac, triac, and T1AM show cytotoxic potential against ovarian cancer. These compounds inhibit proliferation and induce apoptosis, offering a promising new therapeutic avenue for this aggressive disease.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Ovarian cancer is an aggressive malignancy requiring novel therapeutic strategies.
- Thyroid hormones binding to αvβ3 integrin promote ovarian cancer growth.
- Natural thyroid hormone derivatives may antagonize these growth-promoting actions.
Purpose of the Study:
- To investigate the potential of thyroid hormone derivatives (tetrac, triac, T1AM) as novel ovarian cancer treatments.
- To evaluate their effects on cell proliferation, apoptosis, and DNA damage in ovarian cancer cells.
- To explore the role of αvβ3 integrin in their mechanism of action.
Main Methods:
- Studied the effects of tetrac, triac, and T1AM on OVCAR3 and A2780 ovarian cancer cell lines, CHOK1 control cells, and HEK293 cells (αvβ3-deficient or transfected).
- Assessed cell proliferation, apoptosis (using annexin-PI, SubG1/cell-cycle analysis, apoptotic gene expression, caspase-3 and PARP-1 cleavage), and DNA damage markers (ATM, PARP-1).
- Investigated integrin involvement using αvβ3-transfected HEK293 cells and employed a pan-caspase inhibitor to assess caspase-dependent/independent apoptosis.
Main Results:
- Differential inhibition of cell proliferation was observed in ovarian cancer cells compared to control cells.
- Apoptosis was induced in ovarian cancer cells, confirmed by multiple assays, and partially reversed by a pan-caspase inhibitor, suggesting both caspase-dependent and -independent pathways.
- Induction of DNA damage response proteins (ATM, PARP-1) and apoptosis-inducing factor (AIF) was observed in ovarian cancer cells.
- Integrin αvβ3 involvement was demonstrated in the apoptotic effects of triac and T1AM.
Conclusions:
- Tetrac, triac, and T1AM exhibit significant cytotoxic potential against ovarian cancer cells.
- These thyroid hormone derivatives demonstrate anti-proliferative and pro-apoptotic effects, targeting key cellular pathways.
- The findings suggest that these compounds represent a promising novel therapeutic approach for ovarian cancer, potentially involving αvβ3 integrin.
- Further investigation into these natural thyroid hormone derivatives is warranted for ovarian cancer treatment development.
Related Concept Videos
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Functions of Thyroid Hormones
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Inhibition of Cdk Activity
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Replicative Cell Senescence

